APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment of Blastic-Phase CML

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Treatment of Blastic-Phase CML Market Analysis and Forecast 2026-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchTreatment of Blastic-Phase CML Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment of Blastic-Phase CML Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Treatment of Blastic-Phase CML Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment of Blastic-Phase CML Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment of Blastic-Phase CML Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Treatment of Blastic-Phase CML market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Treatment of Blastic-Phase CML is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Treatment of Blastic-Phase CML is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Treatment of Blastic-Phase CML is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Treatment of Blastic-Phase CML is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Treatment of Blastic-Phase CML include Chia Tai Tianqing Pharmaceutical, CSPC Ouyi Pharmaceutical, Qilu Pharmaceutical, Lunan Pharmaceutical, Hansoh Pharmaceutical, HanHui Pharmaceuticals, Takeda Pharmaceuticals, Sanofi and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Treatment of Blastic-Phase CML, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Treatment of Blastic-Phase CML, also provides the sales of main regions and countries. Of the upcoming market potential for Treatment of Blastic-Phase CML, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Treatment of Blastic-Phase CML sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Treatment of Blastic-Phase CML market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Treatment of Blastic-Phase CML sales, projected growth trends, production technology, application and end-user industry.

Treatment of Blastic-Phase CML Segment by Company

Chia Tai Tianqing Pharmaceutical

CSPC Ouyi Pharmaceutical

Qilu Pharmaceutical

Lunan Pharmaceutical

Hansoh Pharmaceutical

HanHui Pharmaceuticals

Takeda Pharmaceuticals

Sanofi

Pfizer

Novartis

Dr. Reddy's Laboratories

Bristol Myers Squibb

Beacon Pharmaceuticals

Apotex

Treatment of Blastic-Phase CML Segment by Type

Targeted Therapy with TKIs

Allogeneic BMT or SCT

Chemotherapy

Others

Treatment of Blastic-Phase CML Segment by Application

Hospitals

Clinics

Others

Treatment of Blastic-Phase CML Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of Blastic-Phase CML market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment of Blastic-Phase CML and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of Blastic-Phase CML.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Treatment of Blastic-Phase CML in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Treatment of Blastic-Phase CML manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Treatment of Blastic-Phase CML sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Treatment of Blastic-Phase CML Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Therapy with TKIs Major Manufacturers Table 3. Allogeneic BMT or SCT Major Manufacturers Table 4. Chemotherapy Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Treatment of Blastic-Phase CML Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Clinics Major Manufacturers Table 9. Others Major Manufacturers Table 10. Treatment of Blastic-Phase CML Industry Trends Table 11. Treatment of Blastic-Phase CML Industry Drivers Table 12. Treatment of Blastic-Phase CML Industry Opportunities and Challenges Table 13. Treatment of Blastic-Phase CML Industry Restraints Table 14. Global Treatment of Blastic-Phase CML Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Treatment of Blastic-Phase CML Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Treatment of Blastic-Phase CML Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Treatment of Blastic-Phase CML Revenue Market Share by Region (2021-2026) Table 18. Global Treatment of Blastic-Phase CML Revenue Market Share by Region (2027-2032) Table 19. Global Treatment of Blastic-Phase CML Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Treatment of Blastic-Phase CML Sales by Region (2021-2026) & (K Units) Table 21. Global Treatment of Blastic-Phase CML Sales by Region (2027-2032) & (K Units) Table 22. Global Treatment of Blastic-Phase CML Sales Market Share by Region (2021-2026) Table 23. Global Treatment of Blastic-Phase CML Sales Market Share by Region (2027-2032) Table 24. Global Treatment of Blastic-Phase CML Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Treatment of Blastic-Phase CML Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Treatment of Blastic-Phase CML Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Treatment of Blastic-Phase CML Sales Market Share by Manufacturers (2021-2026) Table 28. Global Treatment of Blastic-Phase CML Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Treatment of Blastic-Phase CML Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Treatment of Blastic-Phase CML Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Treatment of Blastic-Phase CML Manufacturers, Product Type & Application Table 32. Global Treatment of Blastic-Phase CML Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Treatment of Blastic-Phase CML by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Treatment of Blastic-Phase CML Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Treatment of Blastic-Phase CML Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Treatment of Blastic-Phase CML Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Treatment of Blastic-Phase CML Revenue Market Share by Type (2021-2026) Table 39. Global Treatment of Blastic-Phase CML Revenue Market Share by Type (2027-2032) Table 40. Global Treatment of Blastic-Phase CML Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 42. Global Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 43. Global Treatment of Blastic-Phase CML Sales Market Share by Type (2021-2026) Table 44. Global Treatment of Blastic-Phase CML Sales Market Share by Type (2027-2032) Table 45. Global Treatment of Blastic-Phase CML Price by Type (2021-2026) & (US$/Unit) Table 46. Global Treatment of Blastic-Phase CML Price by Type (2027-2032) & (US$/Unit) Table 47. Global Treatment of Blastic-Phase CML Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Treatment of Blastic-Phase CML Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Treatment of Blastic-Phase CML Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Treatment of Blastic-Phase CML Revenue Market Share by Application (2021-2026) Table 51. Global Treatment of Blastic-Phase CML Revenue Market Share by Application (2027-2032) Table 52. Global Treatment of Blastic-Phase CML Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 54. Global Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 55. Global Treatment of Blastic-Phase CML Sales Market Share by Application (2021-2026) Table 56. Global Treatment of Blastic-Phase CML Sales Market Share by Application (2027-2032) Table 57. Global Treatment of Blastic-Phase CML Price by Application (2021-2026) & (US$/Unit) Table 58. Global Treatment of Blastic-Phase CML Price by Application (2027-2032) & (US$/Unit) Table 59. Chia Tai Tianqing Pharmaceutical Company Information Table 60. Chia Tai Tianqing Pharmaceutical Business Overview Table 61. Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 63. Chia Tai Tianqing Pharmaceutical Recent Development Table 64. CSPC Ouyi Pharmaceutical Company Information Table 65. CSPC Ouyi Pharmaceutical Business Overview Table 66. CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 68. CSPC Ouyi Pharmaceutical Recent Development Table 69. Qilu Pharmaceutical Company Information Table 70. Qilu Pharmaceutical Business Overview Table 71. Qilu Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Qilu Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 73. Qilu Pharmaceutical Recent Development Table 74. Lunan Pharmaceutical Company Information Table 75. Lunan Pharmaceutical Business Overview Table 76. Lunan Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lunan Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 78. Lunan Pharmaceutical Recent Development Table 79. Hansoh Pharmaceutical Company Information Table 80. Hansoh Pharmaceutical Business Overview Table 81. Hansoh Pharmaceutical Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hansoh Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio Table 83. Hansoh Pharmaceutical Recent Development Table 84. HanHui Pharmaceuticals Company Information Table 85. HanHui Pharmaceuticals Business Overview Table 86. HanHui Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. HanHui Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio Table 88. HanHui Pharmaceuticals Recent Development Table 89. Takeda Pharmaceuticals Company Information Table 90. Takeda Pharmaceuticals Business Overview Table 91. Takeda Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Takeda Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio Table 93. Takeda Pharmaceuticals Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sanofi Treatment of Blastic-Phase CML Product Portfolio Table 98. Sanofi Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Pfizer Treatment of Blastic-Phase CML Product Portfolio Table 103. Pfizer Recent Development Table 104. Novartis Company Information Table 105. Novartis Business Overview Table 106. Novartis Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Novartis Treatment of Blastic-Phase CML Product Portfolio Table 108. Novartis Recent Development Table 109. Dr. Reddy's Laboratories Company Information Table 110. Dr. Reddy's Laboratories Business Overview Table 111. Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Product Portfolio Table 113. Dr. Reddy's Laboratories Recent Development Table 114. Bristol Myers Squibb Company Information Table 115. Bristol Myers Squibb Business Overview Table 116. Bristol Myers Squibb Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Bristol Myers Squibb Treatment of Blastic-Phase CML Product Portfolio Table 118. Bristol Myers Squibb Recent Development Table 119. Beacon Pharmaceuticals Company Information Table 120. Beacon Pharmaceuticals Business Overview Table 121. Beacon Pharmaceuticals Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Beacon Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio Table 123. Beacon Pharmaceuticals Recent Development Table 124. Apotex Company Information Table 125. Apotex Business Overview Table 126. Apotex Treatment of Blastic-Phase CML Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Apotex Treatment of Blastic-Phase CML Product Portfolio Table 128. Apotex Recent Development Table 129. North America Treatment of Blastic-Phase CML Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Treatment of Blastic-Phase CML Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 132. North America Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 133. North America Treatment of Blastic-Phase CML Sales Price by Type (2021-2026) & (US$/Unit) Table 134. North America Treatment of Blastic-Phase CML Sales Price by Type (2027-2032) & (US$/Unit) Table 135. North America Treatment of Blastic-Phase CML Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Treatment of Blastic-Phase CML Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 138. North America Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 139. North America Treatment of Blastic-Phase CML Sales Price by Application (2021-2026) & (US$/Unit) Table 140. North America Treatment of Blastic-Phase CML Sales Price by Application (2027-2032) & (US$/Unit) Table 141. North America Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. North America Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. North America Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. North America Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 146. North America Treatment of Blastic-Phase CML Sales by Country (2027-2032) & (K Units) Table 147. North America Treatment of Blastic-Phase CML Sales Price by Country (2021-2026) & (US$/Unit) Table 148. North America Treatment of Blastic-Phase CML Sales Price by Country (2027-2032) & (US$/Unit) Table 149. United States Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 150. Canada Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 151. Mexico Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 152. Europe Treatment of Blastic-Phase CML Revenue by Type (2021-2026) & (US$ Million) Table 153. Europe Treatment of Blastic-Phase CML Revenue by Type (2027-2032) & (US$ Million) Table 154. Europe Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 155. Europe Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 156. Europe Treatment of Blastic-Phase CML Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Europe Treatment of Blastic-Phase CML Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Europe Treatment of Blastic-Phase CML Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Treatment of Blastic-Phase CML Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 161. Europe Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 162. Europe Treatment of Blastic-Phase CML Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Europe Treatment of Blastic-Phase CML Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Europe Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Europe Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Europe Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Europe Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Europe Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 169. Europe Treatment of Blastic-Phase CML Sales by Country (2027-2032) & (K Units) Table 170. Europe Treatment of Blastic-Phase CML Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Europe Treatment of Blastic-Phase CML Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Germany Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 173. France Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 174. U.K. Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 175. Italy Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 176. Russia Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 177. Spain Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 179. Switzerland Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 180. Sweden Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 181. Poland Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 182. China Treatment of Blastic-Phase CML Revenue by Type (2021-2026) & (US$ Million) Table 183. China Treatment of Blastic-Phase CML Revenue by Type (2027-2032) & (US$ Million) Table 184. China Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 185. China Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 186. China Treatment of Blastic-Phase CML Sales Price by Type (2021-2026) & (US$/Unit) Table 187. China Treatment of Blastic-Phase CML Sales Price by Type (2027-2032) & (US$/Unit) Table 188. China Treatment of Blastic-Phase CML Revenue by Application (2021-2026) & (US$ Million) Table 189. China Treatment of Blastic-Phase CML Revenue by Application (2027-2032) & (US$ Million) Table 190. China Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 191. China Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 192. China Treatment of Blastic-Phase CML Sales Price by Application (2021-2026) & (US$/Unit) Table 193. China Treatment of Blastic-Phase CML Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Treatment of Blastic-Phase CML Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Treatment of Blastic-Phase CML Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 197. Asia Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 198. Asia Treatment of Blastic-Phase CML Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Asia Treatment of Blastic-Phase CML Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Asia Treatment of Blastic-Phase CML Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Treatment of Blastic-Phase CML Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 203. Asia Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 204. Asia Treatment of Blastic-Phase CML Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Asia Treatment of Blastic-Phase CML Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. Asia Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 211. Asia Treatment of Blastic-Phase CML Sales by Country (2027-2032) & (K Units) Table 212. Asia Treatment of Blastic-Phase CML Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Asia Treatment of Blastic-Phase CML Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Japan Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 215. South Korea Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 216. India Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 217. Australia Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 218. Taiwan Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Treatment of Blastic-Phase CML Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Treatment of Blastic-Phase CML Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Treatment of Blastic-Phase CML Sales by Type (2021-2026) & (K Units) Table 223. SAMEA Treatment of Blastic-Phase CML Sales by Type (2027-2032) & (K Units) Table 224. SAMEA Treatment of Blastic-Phase CML Sales Price by Type (2021-2026) & (US$/Unit) Table 225. SAMEA Treatment of Blastic-Phase CML Sales Price by Type (2027-2032) & (US$/Unit) Table 226. SAMEA Treatment of Blastic-Phase CML Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Treatment of Blastic-Phase CML Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Treatment of Blastic-Phase CML Sales by Application (2021-2026) & (K Units) Table 229. SAMEA Treatment of Blastic-Phase CML Sales by Application (2027-2032) & (K Units) Table 230. SAMEA Treatment of Blastic-Phase CML Sales Price by Application (2021-2026) & (US$/Unit) Table 231. SAMEA Treatment of Blastic-Phase CML Sales Price by Application (2027-2032) & (US$/Unit) Table 232. SAMEA Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. SAMEA Treatment of Blastic-Phase CML Sales by Country (2021-2026) & (K Units) Table 237. SAMEA Treatment of Blastic-Phase CML Sales by Country (2027-2032) & (K Units) Table 238. SAMEA Treatment of Blastic-Phase CML Sales Price by Country (2021-2026) & (US$/Unit) Table 239. SAMEA Treatment of Blastic-Phase CML Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Brazil Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 241. Argentina Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 242. Chile Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 243. Colombia Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 244. Peru Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 246. Israel Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 247. UAE Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 248. Turkey Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 249. Iran Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 250. Egypt Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Treatment of Blastic-Phase CML Distributors List Table 254. Treatment of Blastic-Phase CML Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Treatment of Blastic-Phase CML Image Figure 2. Global Treatment of Blastic-Phase CML Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment of Blastic-Phase CML Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Therapy with TKIs Image Figure 5. Allogeneic BMT or SCT Image Figure 6. Chemotherapy Image Figure 7. Others Image Figure 8. Global Treatment of Blastic-Phase CML Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Treatment of Blastic-Phase CML Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Others Image Figure 13. Global Treatment of Blastic-Phase CML Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Treatment of Blastic-Phase CML Revenue (2021-2032) & (US$ Million) Figure 15. Global Treatment of Blastic-Phase CML Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Treatment of Blastic-Phase CML Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Treatment of Blastic-Phase CML Revenue Market Share by Region (2021-2032) Figure 18. Global Treatment of Blastic-Phase CML Sales (2021-2032) & (K Units) Figure 19. Global Treatment of Blastic-Phase CML Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Treatment of Blastic-Phase CML Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Treatment of Blastic-Phase CML Sales YoY (2021-2032) & (K Units) Figure 22. Europe Treatment of Blastic-Phase CML Sales YoY (2021-2032) & (K Units) Figure 23. China Treatment of Blastic-Phase CML Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Treatment of Blastic-Phase CML Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Treatment of Blastic-Phase CML Sales YoY (2021-2032) & (K Units) Figure 26. Global Treatment of Blastic-Phase CML Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Treatment of Blastic-Phase CML Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Treatment of Blastic-Phase CML Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Treatment of Blastic-Phase CML Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Treatment of Blastic-Phase CML Revenue Market Share by Type (2021-2032) Figure 32. Global Treatment of Blastic-Phase CML Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Treatment of Blastic-Phase CML Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Treatment of Blastic-Phase CML Sales Market Share by Type (2021-2032) Figure 35. Global Treatment of Blastic-Phase CML Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Treatment of Blastic-Phase CML Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Treatment of Blastic-Phase CML Revenue Market Share by Application (2021-2032) Figure 38. Global Treatment of Blastic-Phase CML Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Treatment of Blastic-Phase CML Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Treatment of Blastic-Phase CML Sales Market Share by Application (2021-2032) Figure 41. North America Treatment of Blastic-Phase CML Revenue Share by Type (2021-2032) Figure 42. North America Treatment of Blastic-Phase CML Sales Share by Type (2021-2032) Figure 43. North America Treatment of Blastic-Phase CML Revenue Share by Application (2021-2032) Figure 44. North America Treatment of Blastic-Phase CML Sales Share by Application (2021-2032) Figure 45. North America Treatment of Blastic-Phase CML Revenue Share by Country (2021-2032) Figure 46. North America Treatment of Blastic-Phase CML Sales Share by Country (2021-2032) Figure 47. Europe Treatment of Blastic-Phase CML Revenue Share by Type (2021-2032) Figure 48. Europe Treatment of Blastic-Phase CML Sales Share by Type (2021-2032) Figure 49. Europe Treatment of Blastic-Phase CML Revenue Share by Application (2021-2032) Figure 50. Europe Treatment of Blastic-Phase CML Sales Share by Application (2021-2032) Figure 51. Europe Treatment of Blastic-Phase CML Revenue Share by Country (2021-2032) Figure 52. Europe Treatment of Blastic-Phase CML Sales Share by Country (2021-2032) Figure 53. China Treatment of Blastic-Phase CML Revenue Share by Type (2021-2032) Figure 54. China Treatment of Blastic-Phase CML Sales Share by Type (2021-2032) Figure 55. China Treatment of Blastic-Phase CML Revenue Share by Application (2021-2032) Figure 56. China Treatment of Blastic-Phase CML Sales Share by Application (2021-2032) Figure 57. Asia Treatment of Blastic-Phase CML Revenue Share by Type (2021-2032) Figure 58. Asia Treatment of Blastic-Phase CML Sales Share by Type (2021-2032) Figure 59. Asia Treatment of Blastic-Phase CML Revenue Share by Application (2021-2032) Figure 60. Asia Treatment of Blastic-Phase CML Sales Share by Application (2021-2032) Figure 61. Asia Treatment of Blastic-Phase CML Revenue Share by Country (2021-2032) Figure 62. Asia Treatment of Blastic-Phase CML Sales Share by Country (2021-2032) Figure 63. SAMEA Treatment of Blastic-Phase CML Revenue Share by Type (2021-2032) Figure 64. SAMEA Treatment of Blastic-Phase CML Sales Share by Type (2021-2032) Figure 65. SAMEA Treatment of Blastic-Phase CML Revenue Share by Application (2021-2032) Figure 66. SAMEA Treatment of Blastic-Phase CML Sales Share by Application (2021-2032) Figure 67. SAMEA Treatment of Blastic-Phase CML Revenue Share by Country (2021-2032) Figure 68. SAMEA Treatment of Blastic-Phase CML Sales Share by Country (2021-2032) Figure 69. Treatment of Blastic-Phase CML Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Treatment of Blastic-Phase CML Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy with TKIs
  • Allogeneic BMT or SCT
  • Chemotherapy
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Qilu Pharmaceutical
  • Lunan Pharmaceutical
  • Hansoh Pharmaceutical
  • HanHui Pharmaceuticals
  • Takeda Pharmaceuticals
  • Sanofi
  • Pfizer
  • Novartis
  • Dr. Reddy's Laboratories
  • Bristol Myers Squibb
  • Beacon Pharmaceuticals
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Treatment of Blastic-Phase CML Market by Type
  3. 1.2.1 Global Treatment of Blastic-Phase CML Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Therapy with TKIs
  5. 1.2.3 Allogeneic BMT or SCT
  6. 1.2.4 Chemotherapy
  7. 1.2.5 Others
  8. 1.3 Treatment of Blastic-Phase CML Market by Application
  9. 1.3.1 Global Treatment of Blastic-Phase CML Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinics
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Treatment of Blastic-Phase CML Market Dynamics
  1. 2.1 Treatment of Blastic-Phase CML Industry Trends
  2. 2.2 Treatment of Blastic-Phase CML Industry Drivers
  3. 2.3 Treatment of Blastic-Phase CML Industry Opportunities and Challenges
  4. 2.4 Treatment of Blastic-Phase CML Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Treatment of Blastic-Phase CML Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Treatment of Blastic-Phase CML Revenue by Region
  3. 3.2.1 Global Treatment of Blastic-Phase CML Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Treatment of Blastic-Phase CML Revenue by Region (2021-2026)
  5. 3.2.3 Global Treatment of Blastic-Phase CML Revenue by Region (2027-2032)
  6. 3.2.4 Global Treatment of Blastic-Phase CML Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Treatment of Blastic-Phase CML Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Treatment of Blastic-Phase CML Sales by Region
  9. 3.4.1 Global Treatment of Blastic-Phase CML Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Treatment of Blastic-Phase CML Sales by Region (2021-2026)
  11. 3.4.3 Global Treatment of Blastic-Phase CML Sales by Region (2027-2032)
  12. 3.4.4 Global Treatment of Blastic-Phase CML Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Treatment of Blastic-Phase CML Revenue by Manufacturers
  2. 4.1.1 Global Treatment of Blastic-Phase CML Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Treatment of Blastic-Phase CML Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Treatment of Blastic-Phase CML Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Treatment of Blastic-Phase CML Sales by Manufacturers
  6. 4.2.1 Global Treatment of Blastic-Phase CML Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Treatment of Blastic-Phase CML Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Treatment of Blastic-Phase CML Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Treatment of Blastic-Phase CML Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Treatment of Blastic-Phase CML Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Treatment of Blastic-Phase CML Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Treatment of Blastic-Phase CML Manufacturers, Product Type & Application
  13. 4.7 Global Treatment of Blastic-Phase CML Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Treatment of Blastic-Phase CML Market CR5 and HHI
  16. 4.8.2 2025 Treatment of Blastic-Phase CML Tier 1, Tier 2, and Tier 3
5 Treatment of Blastic-Phase CML Market by Type
  1. 5.1 Global Treatment of Blastic-Phase CML Revenue by Type
  2. 5.1.1 Global Treatment of Blastic-Phase CML Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Treatment of Blastic-Phase CML Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Treatment of Blastic-Phase CML Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Treatment of Blastic-Phase CML Sales by Type
  6. 5.2.1 Global Treatment of Blastic-Phase CML Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Treatment of Blastic-Phase CML Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Treatment of Blastic-Phase CML Sales Market Share by Type (2021-2032)
  9. 5.3 Global Treatment of Blastic-Phase CML Price by Type
6 Treatment of Blastic-Phase CML Market by Application
  1. 6.1 Global Treatment of Blastic-Phase CML Revenue by Application
  2. 6.1.1 Global Treatment of Blastic-Phase CML Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Treatment of Blastic-Phase CML Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Treatment of Blastic-Phase CML Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Treatment of Blastic-Phase CML Sales by Application
  6. 6.2.1 Global Treatment of Blastic-Phase CML Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Treatment of Blastic-Phase CML Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Treatment of Blastic-Phase CML Sales Market Share by Application (2021-2032)
  9. 6.3 Global Treatment of Blastic-Phase CML Price by Application
7 Company Profiles
  1. 7.1 Chia Tai Tianqing Pharmaceutical
  2. 7.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 7.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 7.1.3 Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chia Tai Tianqing Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  6. 7.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 7.2 CSPC Ouyi Pharmaceutical
  8. 7.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 7.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 7.2.3 CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSPC Ouyi Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  12. 7.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 7.3 Qilu Pharmaceutical
  14. 7.3.1 Qilu Pharmaceutical Company Information
  15. 7.3.2 Qilu Pharmaceutical Business Overview
  16. 7.3.3 Qilu Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Recent Developments
  19. 7.4 Lunan Pharmaceutical
  20. 7.4.1 Lunan Pharmaceutical Company Information
  21. 7.4.2 Lunan Pharmaceutical Business Overview
  22. 7.4.3 Lunan Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lunan Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  24. 7.4.5 Lunan Pharmaceutical Recent Developments
  25. 7.5 Hansoh Pharmaceutical
  26. 7.5.1 Hansoh Pharmaceutical Company Information
  27. 7.5.2 Hansoh Pharmaceutical Business Overview
  28. 7.5.3 Hansoh Pharmaceutical Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hansoh Pharmaceutical Treatment of Blastic-Phase CML Product Portfolio
  30. 7.5.5 Hansoh Pharmaceutical Recent Developments
  31. 7.6 HanHui Pharmaceuticals
  32. 7.6.1 HanHui Pharmaceuticals Company Information
  33. 7.6.2 HanHui Pharmaceuticals Business Overview
  34. 7.6.3 HanHui Pharmaceuticals Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 HanHui Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio
  36. 7.6.5 HanHui Pharmaceuticals Recent Developments
  37. 7.7 Takeda Pharmaceuticals
  38. 7.7.1 Takeda Pharmaceuticals Company Information
  39. 7.7.2 Takeda Pharmaceuticals Business Overview
  40. 7.7.3 Takeda Pharmaceuticals Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Takeda Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio
  42. 7.7.5 Takeda Pharmaceuticals Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Treatment of Blastic-Phase CML Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Treatment of Blastic-Phase CML Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Treatment of Blastic-Phase CML Product Portfolio
  60. 7.10.5 Novartis Recent Developments
  61. 7.11 Dr. Reddy's Laboratories
  62. 7.11.1 Dr. Reddy's Laboratories Company Information
  63. 7.11.2 Dr. Reddy's Laboratories Business Overview
  64. 7.11.3 Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Dr. Reddy's Laboratories Treatment of Blastic-Phase CML Product Portfolio
  66. 7.11.5 Dr. Reddy's Laboratories Recent Developments
  67. 7.12 Bristol Myers Squibb
  68. 7.12.1 Bristol Myers Squibb Company Information
  69. 7.12.2 Bristol Myers Squibb Business Overview
  70. 7.12.3 Bristol Myers Squibb Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bristol Myers Squibb Treatment of Blastic-Phase CML Product Portfolio
  72. 7.12.5 Bristol Myers Squibb Recent Developments
  73. 7.13 Beacon Pharmaceuticals
  74. 7.13.1 Beacon Pharmaceuticals Company Information
  75. 7.13.2 Beacon Pharmaceuticals Business Overview
  76. 7.13.3 Beacon Pharmaceuticals Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Beacon Pharmaceuticals Treatment of Blastic-Phase CML Product Portfolio
  78. 7.13.5 Beacon Pharmaceuticals Recent Developments
  79. 7.14 Apotex
  80. 7.14.1 Apotex Company Information
  81. 7.14.2 Apotex Business Overview
  82. 7.14.3 Apotex Treatment of Blastic-Phase CML Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Apotex Treatment of Blastic-Phase CML Product Portfolio
  84. 7.14.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Treatment of Blastic-Phase CML Market Size by Type
  2. 8.1.1 North America Treatment of Blastic-Phase CML Revenue by Type (2021-2032)
  3. 8.1.2 North America Treatment of Blastic-Phase CML Sales by Type (2021-2032)
  4. 8.1.3 North America Treatment of Blastic-Phase CML Price by Type (2021-2032)
  5. 8.2 North America Treatment of Blastic-Phase CML Market Size by Application
  6. 8.2.1 North America Treatment of Blastic-Phase CML Revenue by Application (2021-2032)
  7. 8.2.2 North America Treatment of Blastic-Phase CML Sales by Application (2021-2032)
  8. 8.2.3 North America Treatment of Blastic-Phase CML Price by Application (2021-2032)
  9. 8.3 North America Treatment of Blastic-Phase CML Market Size by Country
  10. 8.3.1 North America Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Treatment of Blastic-Phase CML Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Treatment of Blastic-Phase CML Market Size by Type
  2. 9.1.1 Europe Treatment of Blastic-Phase CML Revenue by Type (2021-2032)
  3. 9.1.2 Europe Treatment of Blastic-Phase CML Sales by Type (2021-2032)
  4. 9.1.3 Europe Treatment of Blastic-Phase CML Price by Type (2021-2032)
  5. 9.2 Europe Treatment of Blastic-Phase CML Market Size by Application
  6. 9.2.1 Europe Treatment of Blastic-Phase CML Revenue by Application (2021-2032)
  7. 9.2.2 Europe Treatment of Blastic-Phase CML Sales by Application (2021-2032)
  8. 9.2.3 Europe Treatment of Blastic-Phase CML Price by Application (2021-2032)
  9. 9.3 Europe Treatment of Blastic-Phase CML Market Size by Country
  10. 9.3.1 Europe Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Treatment of Blastic-Phase CML Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Treatment of Blastic-Phase CML Market Size by Type
  2. 10.1.1 China Treatment of Blastic-Phase CML Revenue by Type (2021-2032)
  3. 10.1.2 China Treatment of Blastic-Phase CML Sales by Type (2021-2032)
  4. 10.1.3 China Treatment of Blastic-Phase CML Price by Type (2021-2032)
  5. 10.2 China Treatment of Blastic-Phase CML Market Size by Application
  6. 10.2.1 China Treatment of Blastic-Phase CML Revenue by Application (2021-2032)
  7. 10.2.2 China Treatment of Blastic-Phase CML Sales by Application (2021-2032)
  8. 10.2.3 China Treatment of Blastic-Phase CML Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Treatment of Blastic-Phase CML Market Size by Type
  2. 11.1.1 Asia Treatment of Blastic-Phase CML Revenue by Type (2021-2032)
  3. 11.1.2 Asia Treatment of Blastic-Phase CML Sales by Type (2021-2032)
  4. 11.1.3 Asia Treatment of Blastic-Phase CML Price by Type (2021-2032)
  5. 11.2 Asia Treatment of Blastic-Phase CML Market Size by Application
  6. 11.2.1 Asia Treatment of Blastic-Phase CML Revenue by Application (2021-2032)
  7. 11.2.2 Asia Treatment of Blastic-Phase CML Sales by Application (2021-2032)
  8. 11.2.3 Asia Treatment of Blastic-Phase CML Price by Application (2021-2032)
  9. 11.3 Asia Treatment of Blastic-Phase CML Market Size by Country
  10. 11.3.1 Asia Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Treatment of Blastic-Phase CML Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Treatment of Blastic-Phase CML Market Size by Type
  2. 12.1.1 SAMEA Treatment of Blastic-Phase CML Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Treatment of Blastic-Phase CML Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Treatment of Blastic-Phase CML Price by Type (2021-2032)
  5. 12.2 SAMEA Treatment of Blastic-Phase CML Market Size by Application
  6. 12.2.1 SAMEA Treatment of Blastic-Phase CML Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Treatment of Blastic-Phase CML Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Treatment of Blastic-Phase CML Price by Application (2021-2032)
  9. 12.3 SAMEA Treatment of Blastic-Phase CML Market Size by Country
  10. 12.3.1 SAMEA Treatment of Blastic-Phase CML Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Treatment of Blastic-Phase CML Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Treatment of Blastic-Phase CML Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Treatment of Blastic-Phase CML Value Chain Analysis
  2. 13.1.1 Treatment of Blastic-Phase CML Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Treatment of Blastic-Phase CML Production Mode & Process
  6. 13.2 Treatment of Blastic-Phase CML Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Treatment of Blastic-Phase CML Distributors
  9. 13.2.3 Treatment of Blastic-Phase CML Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst